89bio, Inc. Proceeds from Common Stock Issued
89bio, Inc. reported Proceeds from Common Stock Issued of $268.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2024-03-01
- 89bio, Inc. proceeds from issuance of common stock for the quarter ending 2023-12-31 was $126.00K, a 1700.00% increase year-over-year.
- 89bio, Inc. proceeds from issuance of common stock for the quarter ending 2023-09-30 was $0.00.
- 89bio, Inc. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $7.00K, a 88.52% decline year-over-year.
- 89bio, Inc. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $0.00.
- 89bio, Inc. proceeds from issuance of common stock for fiscal 2023 was $268.00K, a 436.00% increase from fiscal 2022.
- 89bio, Inc. proceeds from issuance of common stock for fiscal 2022 was $50.00K, a 65.28% decline from fiscal 2021.
- 89bio, Inc. proceeds from issuance of common stock for fiscal 2021 was $144.00K.
- 89bio, Inc. proceeds from issuance of common stock for fiscal 2019 was $11.00K.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2023-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $126.00K derived: sum of 2 quarters · filed 2024-03-01 | $268.00K 10-K · filed 2024-03-01 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $142.00K 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $142.00K 10-Q · filed 2023-08-09 | |||
| 2022-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $7.00K derived: sum of 2 quarters · filed 2024-03-01 | $50.00K 10-K · filed 2024-03-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $43.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $43.00K 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $61.00K derived: sum of 2 quarters · filed 2024-03-01 | $144.00K 10-K · filed 2024-03-01 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $83.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $83.00K 10-Q · filed 2022-08-11 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $11.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $11.00K 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | $11.00K 10-Q · filed 2020-08-13 |